X

Xigen

50 employees

Xigen, a biopharmaceutical company, develops therapeutics to inhibit intracellular protein interactions.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Biopharma

Date founded

2002

Funding rounds raised

Total raised

$21M

from 1 investors over 1 rounds

X

Xigen raised $21M on September 6, 2005

Investors: VI Partners AG

FAQ